Royalty Pharma simplifies corporate structure with $1.1 bln deal

Royalty Pharma

10/01/2025 12:27

Jan 10 (Reuters) - Royalty Pharma  RPRX.O  said on
Friday it would pay about $1.1 billion to acquire RP Management,
an organization that manages its operations as the healthcare
firm seeks to simplify corporate structure.
    Royalty Pharma buys royalties of future drugs from academic
labs and biotechnology companies, which in turn use the cash to
fund their research.

 (Reporting by Bhanvi Satija in Bengaluru; Editing by Shilpi
Majumdar)
 ((Bhanvi.Satija@thomsonreuters.com; Outside U.S. +91
9873062788;))